Litcius/Paper detail

Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered <i>Runx1</i> splicing

Marisa J.L. Aitken, Prerna Malaney, Xiaorui Zhang, Shelley M. Herbrich, Lauren Chan, Oscar Benitez, Ashley Rodriguez, Huaxian Ma, Rodrigo Jácamo, Ruizhi Duan, Todd Link, Steven M. Kornblau, Rashmi Kanagal‐Shamanna, Carlos E. Bueso‐Ramos, Sean M. Post

2022NAR Cancer13 citationsDOIOpen Access PDF

Abstract

Abstract Acute myeloid leukemia (AML) is driven by numerous molecular events that contribute to disease progression. Herein, we identify hnRNP K overexpression as a recurrent abnormality in AML that negatively correlates with patient survival. Overexpression of hnRNP K in murine fetal liver cells results in altered self-renewal and differentiation potential. Further, murine transplantation models reveal that hnRNP K overexpression results in myeloproliferation in vivo. Mechanistic studies expose a direct functional relationship between hnRNP K and RUNX1—a master transcriptional regulator of hematopoiesis often dysregulated in leukemia. Molecular analyses show that overexpression of hnRNP K results in an enrichment of an alternatively spliced isoform of RUNX1 lacking exon 4. Our work establishes hnRNP K’s oncogenic potential in influencing myelogenesis through its regulation of RUNX1 splicing and subsequent transcriptional activity.

Topics & Concepts

RUNX1Heterogeneous nuclear ribonucleoproteinMyeloid leukemiaLeukemiaCancer researchBiologyAlternative splicingRibonucleoproteinRNA splicingMyeloidExonHaematopoiesisMolecular biologyStem cellCell biologyImmunologyGeneticsGeneRNARNA Research and SplicingAcute Myeloid Leukemia ResearchRNA modifications and cancer